BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27698439)

  • 1. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Vidal AC; Howard LE; Sun SX; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):72-78. PubMed ID: 27698439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
    Mithal P; Howard LE; Aronson WJ; Terris MK; Cooperberg MR; Kane CJ; Amling C; Freedland SJ
    BJU Int; 2016 Feb; 117(2):244-8. PubMed ID: 26010160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, race, and long-term prostate cancer outcomes.
    Vidal AC; Oyekunle T; Howard LE; De Hoedt AM; Kane CJ; Terris MK; Cooperberg MR; Amling CL; Klaassen Z; Freedland SJ; Aronson WJ
    Cancer; 2020 Aug; 126(16):3733-3741. PubMed ID: 32497282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Vidal AC; Howard LE; de Hoedt A; Kane CJ; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Freedland SJ
    BJU Int; 2018 Jul; 122(1):76-82. PubMed ID: 29521009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy.
    Kelkar S; Oyekunle T; Eisenberg A; Howard L; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen Z; Terris MK; Freedland SJ; Csizmadi I
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34169227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Boffetta P; Freedland SJ
    Cancer; 2014 Jan; 120(2):197-204. PubMed ID: 24127391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
    Freedland SJ; Branche BL; Howard LE; Hamilton RJ; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ;
    BJU Int; 2019 Jul; 124(1):69-75. PubMed ID: 30347135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
    Allott EH; Abern MR; Gerber L; Keto CJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moorman PG; Freedland SJ
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):391-7. PubMed ID: 24100644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.
    Mauermann J; Fradet V; Lacombe L; Dujardin T; Tiguert R; Tetu B; Fradet Y
    Eur Urol; 2013 Jul; 64(1):19-25. PubMed ID: 22901983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
    Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort.
    Liu IT; Gu L; De Hoedt AM; Cooperberg MR; Amling CL; Kane CJ; Klaassen Z; Terris MK; Guerrios-Rivera L; Vidal AC; Aronson WJ; Freedland SJ; Csizmadi I
    Cancer Causes Control; 2023 Nov; 34(11):983-993. PubMed ID: 37405681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.
    Maj-Hes AB; Mathieu R; Özsoy M; Soria F; Moschini M; Abufaraj M; Briganti A; Roupret M; Karakiewicz PI; Klatte T; Shariat SF
    Urol Oncol; 2017 Jul; 35(7):460.e1-460.e8. PubMed ID: 28460801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and long-term survival after radical prostatectomy.
    Chalfin HJ; Lee SB; Jeong BC; Freedland SJ; Alai H; Feng Z; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
    J Urol; 2014 Oct; 192(4):1100-4. PubMed ID: 24769031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
    Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
    Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
    Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
    Wu C; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2013 Jun; 111(8):E310-8. PubMed ID: 23305170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy.
    Yu YD; Byun SS; Lee SE; Hong SK
    Sci Rep; 2018 Aug; 8(1):11962. PubMed ID: 30097640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH.
    Griffin K; Csizmadi I; Howard LE; Pomann GM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Beebe-Dimmer J; Freedland SJ
    Cancer Causes Control; 2019 Mar; 30(3):259-269. PubMed ID: 30701374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.